January 7, 2026 · Form 4 insider transaction
Boulding Mark Elliott bought 2,625 shares of PTC Therapeutics Inc at $38.10 per share, a transaction worth $100.0K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 4, 2024.